| 1 | Approve Financial Statements | For |
| 2 | Approve appropriation of the accumulated loss for fiscal year 2025 | For |
| 3 | Discharge the Board of Directors and the Executive Management | Oppose |
| 4a | Elect Olivier Brandicourt - Non-Executive Director | For |
| 4b | Elect Margaret Dugan - Non-Executive Director | Oppose |
| 4c | Elect Anthony Hooper - Non-Executive Director | Oppose |
| 4d | Elect John V. Oyler - Chair & Chief Executive | Oppose |
| 4e | Elect Alessandro Riva - Non-Executive Director | Oppose |
| 4f | Elect Shalini Sharp - Non-Executive Director | Oppose |
| 4g | Elect Xiaodong Wang - Non-Executive Director | For |
| 4h | Elect Felix J. Baker - Non-Executive Director | Oppose |
| 4i | Elect Elizabeth F. Mooney - Non-Executive Director | For |
| 4j | Elect Charles L. Sawyers - Non-Executive Director | For |
| 5 | Elect John V. Oyler as Chair | Oppose |
| 6a | Elect Remuneration Committee Member: Margaret Dugan | For |
| 6b | Elect Remuneration Committee: Elizabeth F. Mooney | For |
| 7 | Appointment of Schweiger Advokatur/Notariat as independent proxy-holder | For |
| 8 | Appoint the Auditors: EY | For |
| 9 | Allow the Board to Determine the Auditor's Remuneration | For |
| 10 | Advisory Vote on Executive Compensation | Oppose |
| 11 | Approve Fees Payable to the Board of Directors | Oppose |
| 12 | Fixed Remuneration of Executive Management Team for fiscal year 2027 | Oppose |
| 13 | Approve the Remuneration Report | Oppose |
| 14 | Approve Non-Financial Statements | For |
| 15a | Approve Amended and Restated 2016 Share Option and Incentive Plan | Oppose |
| 15b | Approve the consultant sublimit in the Fifth Amended and Restated 2016 Share Option and Incentive Plan | Oppose |
| 16 | Approve Sixth Amended and Restated 2018 Employee Share Purchase Plan | Oppose |
| 17 | Approve General Share Issue Mandate | For |
| 18 | Authorise Share Repurchase | For |
| 19 | Approve Issue of Shares for Private Placement to Amgen Inc | Oppose |
| 20 | Allow Proxy Solicitation | Oppose |
| 21 | Transact Any Other Business | Oppose |
